Article Versions Notes

Karakitsios E, Angelerou M-F-G, Kapralos I, Tsakiridou G, Kalantzi L, Dokoumetzidis A. Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus. Pharmaceutics. 2025; 17(2):227. https://doi.org/10.3390/pharmaceutics17020227

Karakitsios, Evangelos, Maria-Faidra-Galini Angelerou, Iasonas Kapralos, Georgia Tsakiridou, Lida Kalantzi, and Aristides Dokoumetzidis. 2025. "Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus" Pharmaceutics 17, no. 2: 227. https://doi.org/10.3390/pharmaceutics17020227

Karakitsios, E., Angelerou, M.-F.-G., Kapralos, I., Tsakiridou, G., Kalantzi, L., & Dokoumetzidis, A. (2025). Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus. Pharmaceutics, 17(2), 227. https://doi.org/10.3390/pharmaceutics17020227